Sun Pharmaceutical Industries Limited
SUNPHARMA
Rang in Aktien
#521
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Aktienkurs
$19.24
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$46.15B
Veränderung (1 Tag)
-0.97%
Veränderung (1 Jahr)
0.11%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategorie
Healthcare
P/S-Verhältnis für Sun Pharmaceutical Industries Limited (SUNPHARMA)
P/S-Verhältnis zum October 2026 TTM: 7.06
Laut den neuesten Finanzberichten und dem Aktienkurs von Sun Pharmaceutical Industries Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 7.06. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 8.06.
P/S-Verlauf für Sun Pharmaceutical Industries Limited von 2004 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 7.06 | -8.81% |
| 2025 | 7.74 | -3.96% |
| 2024 | 8.06 | 49.97% |
| 2023 | 5.37 | -5.34% |
| 2022 | 5.68 | 32.61% |
| 2021 | 4.28 | 66.34% |
| 2020 | 2.57 | -34.88% |
| 2019 | 3.95 | -14.31% |
| 2018 | 4.61 | -12.68% |
| 2017 | 5.28 | -24.75% |
| 2016 | 7.02 | -21.91% |
| 2015 | 8.99 | 21.43% |
| 2014 | 7.40 | -0.77% |
| 2013 | 7.46 | 1.13% |
| 2012 | 7.38 | -7.90% |
| 2011 | 8.01 | -15.75% |
| 2010 | 9.51 | 76.44% |
| 2009 | 5.39 | -26.13% |
| 2008 | 7.29 | -21.66% |
| 2007 | 9.31 | -4.42% |
| 2006 | 9.74 | 34.88% |
| 2005 | 7.22 | 17.66% |
| 2004 | 6.14 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
